282 related articles for article (PubMed ID: 10028017)
1. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
Peterson KE; Braley-Mullen H
J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Kyriakos M
J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200
[TBL] [Abstract][Full Text] [Related]
3. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody.
Stull SJ; Sharp GC; Kyriakos M; Bickel JT; Braley-Mullen H
J Immunol; 1992 Sep; 149(6):2219-26. PubMed ID: 1517579
[TBL] [Abstract][Full Text] [Related]
4. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC
J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
[TBL] [Abstract][Full Text] [Related]
6. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.
Zhang W; Flynn JC; Kong YC
Cell Immunol; 2001 Feb; 208(1):52-61. PubMed ID: 11277619
[TBL] [Abstract][Full Text] [Related]
7. Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice.
Tang H; Sharp GC; Peterson KE; Braley-Mullen H
J Immunol; 1998 Jan; 160(1):155-62. PubMed ID: 9551967
[TBL] [Abstract][Full Text] [Related]
8. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
[TBL] [Abstract][Full Text] [Related]
9. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis.
Peterson KE; Sharp GC; Tang H; Braley-Mullen H
J Immunol; 1999 Feb; 162(3):1859-67. PubMed ID: 9973452
[TBL] [Abstract][Full Text] [Related]
10. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids.
Tang H; Sharp GC; Peterson KP; Braley-Mullen H
J Immunol; 1998 May; 160(10):5105-12. PubMed ID: 9590262
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
13. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody.
Braley-Mullen H; Sharp GC; Bickel JT; Kyriakos M
J Exp Med; 1991 Apr; 173(4):899-912. PubMed ID: 1672546
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Tang H; Chen K; Kyriakos M; Bickel JT
Am J Pathol; 1998 May; 152(5):1347-58. PubMed ID: 9588903
[TBL] [Abstract][Full Text] [Related]
15. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin.
Peterson KE; Braley-Mullen H
Cell Immunol; 1995 Nov; 166(1):123-30. PubMed ID: 7585972
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
Tang H; Braley-Mullen H
Int Immunol; 1997 May; 9(5):679-87. PubMed ID: 9184913
[TBL] [Abstract][Full Text] [Related]
17. The kinetics of cytokine gene expression in the thyroids of mice developing granulomatous experimental autoimmune thyroiditis.
Tang H; Sharp GC; Chen K; Braley-Mullen H
J Autoimmun; 1998 Dec; 11(6):581-9. PubMed ID: 9878080
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor V beta usage in murine experimental autoimmune thyroiditis.
McMurray RW; Hoffman RW; Tang H; Braley-Mullen H
Cell Immunol; 1996 Aug; 172(1):1-9. PubMed ID: 8806800
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
20. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT.
Mignon-Godefroy K; Rott O; Brazillet MP; Charreire J
J Immunol; 1995 Jun; 154(12):6634-43. PubMed ID: 7759896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
